Home » ANGIOTECH ANNOUNCES POSITIVE INTERIM SAFETY DATA WITH VASCULAR WRAP AT ONE YEAR
ANGIOTECH ANNOUNCES POSITIVE INTERIM SAFETY DATA WITH VASCULAR WRAP AT ONE YEAR
Angiotech Pharmaceuticals recently announced positive interim 12-month safety
results from its novel and proprietary Vascular Wrap paclitaxel-eluting mesh
trial presented at the VEITHsymposium in New York. This European first-in-man
pilot study is designed to evaluate the safety of a novel and proprietary drug-loaded
Vascular Wrap in the prevention of stenosis after peripheral bypass surgery.
Biotech
Intelligence
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May